Coronavirus: Remdesivir has ‘little effect’ on death risks, says WHO
BREAKING NEWS: Remdesivir has ‘little effect’ on COVID-19 death risks, WHO study study finds The antiviral remdesivir is one of just two COVID-19 treatments that has emergency FDA approval in the US A WHO trial of 11,266 hospitalized COVID-19 patients tested remdesivir, hydroxychloroquine, lopinavir and interferon treatments The SOLIDARITY trial found that none of the four … Read more